Data / Form D filings / Canton Strategic Holdings, Inc.
Canton Strategic Holdings, Inc.: Form D filings
Canton Strategic Holdings, Inc., a biotechnology company in Red Bank, NJ, filed 5 Form D notices with the SEC between 2024 and 2026. The latest, on April 15, 2026, reports $1.2 million sold of a $1.2 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 34 SHREWSBURY AVE., Red Bank, NJ, 07701
- Phone
- (732) 889-3111
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1861657
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | New notice | $1,225,003 | $1,225,003 | 6 | Jul 25, 2025 | sec.gov | |
| Apr 15, 2026 | New notice | $1,740,000 | $1,740,000 | 13 | Jul 23, 2025 | sec.gov | |
| Jul 7, 2025 | New notice | $2,500,000 | $2,500,000 | 30 | Jun 13, 2025 | sec.gov | |
| Dec 17, 2024 | New notice | $2,020,000 | $2,020,000 | 7 | Dec 9, 2024 | sec.gov | |
| Jun 28, 2024 | New notice | $2,084,160 | $2,084,160 | 5 | Jun 18, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark Wendland | Executive Officer, Director | Chief Executive Officer |
| Jacob Asbury | Executive Officer | Chief Financial Officer |
| Angela Radkowski | Executive Officer | Chief Operating Officer |
| Mark Toomey | Executive Officer | President |
| Vincent LoPriore | Director | |
| Sireesh Appajosyula | Director | |
| Clay Kahler | Director | |
| Gary Stetz | Director | |
| Jill Sommers | Director | |
| William Wiley | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
- Bullseye Biodevices, Inc. $1.3 million · Aug 10, 2026
- Hepion Pharmaceuticals, Inc. $3.1 million · Aug 5, 2026
Every Form D from the week of Apr 13, 2026 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Canton Strategic Holdings, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.